enow.com Web Search

  1. Ads

    related to: lvad long-term survival

Search results

  1. Results from the WOW.Com Content Network
  2. Ventricular assist device - Wikipedia

    en.wikipedia.org/wiki/Ventricular_assist_device

    The study found that the device improved outcomes, both compared to other LVAD treatments and baseline patients. Specifically, HeartMate II patients showed lower creatinine levels, 30-day survival rates were considerably higher at 96%, and 93% reached successful outcomes (transplant, cardiac recovery, or long-term LVAD). [56]

  3. Destination therapy - Wikipedia

    en.wikipedia.org/wiki/Destination_therapy

    In 2000, the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial was conducted. REMATCH was a multi-center study supported by the National Heart, Lung, and Blood Institute to compare long-term implantation of left ventricular assist devices with optimal medical management for patients with end-stage heart failure who require, but do not ...

  4. William F. Bernhard - Wikipedia

    en.wikipedia.org/wiki/William_F._Bernhard

    Bernhard and his staff worked to complete long term clinical trial studies [15] and eventually a subsidiary company of Thermedic’s, Thermo Cardiosystems merged with Thoratec Laboratories Corporation (Nasdaq: THOR), and obtained FDA approval in 2002 of the “Heartmate” LVAD device [16] Thoratec Heartmate II LVAD device is used in ...

  5. Thoratec - Wikipedia

    en.wikipedia.org/wiki/Thoratec

    With the 2001 Thermo Cardiosystems merger, Thoratec acquired the HeartMate Left Ventricular Assist System, an implanted VAD for end-stage heart patients. A landmark three-year study of 129 patients at 22 major medical centers, called REMATCH (Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure) and published in November 2001, found that the HeartMate VE ...

  6. Cardiac contractility modulation - Wikipedia

    en.wikipedia.org/wiki/Cardiac_contractility...

    The FDA approved the OPTIMIZER Smart System, which delivers cardiac contractility modulation therapy, as indicated to improve 6-minute hall walk distance, quality of life, and functional status of NYHA Class III heart failure patients who remain symptomatic despite guideline directed medical therapy, who are in normal sinus rhythm, are not indicated for cardiac resynchronization therapy, and ...

  7. '1923' actress died for 3 minutes, suffered complete organ ...

    www.aol.com/news/1923-actress-died-3-minutes...

    Original article source: '1923' actress died for 3 minutes, suffered complete organ failure during weeks-long health battle. Show comments. Advertisement. Advertisement. Holiday Shopping Guides.

  8. 7 Alternatives to Chemotherapy for Lymphoma in Dogs - AOL

    www.aol.com/7-alternatives-chemotherapy-lymphoma...

    1. Ketogenic Diet. Cancer cells rely on glucose for energy to grow. The ketogenic diet is a way to provide an alternative energy source to normal cells in the dog's body while starving the cancer ...

  9. AOL Mail - AOL Help

    help.aol.com/products/aol-webmail

    Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.

  1. Ads

    related to: lvad long-term survival